Literature DB >> 23850572

Differential role of ventral tegmental area acetylcholine and N-methyl-D-aspartate receptors in cocaine-seeking.

Wojciech Solecki1, Robert J Wickham2, Shay Behrens1, Jie Wang3, Blake Zwerling1, Graeme F Mason4, Nii A Addy5.   

Abstract

Exposure to drug-associated cues evokes drug-seeking behavior and is regarded as a major cause of relapse. Cues evoke burst firing of ventral tegmental area (VTA) dopamine (DA) neurons and phasic DA release in the nucleus accumbens (NAc). Cholinergic and glutamatergic input to the VTA is suggested to gate phasic DA activity. However, the role of VTA cholinergic and glutamatergic receptors in regulating phasic dopamine release and cue-induced drug-seeking in cocaine experienced subjects is not known. In male Sprague-Dawley rats, we found that VTA inactivation strongly inhibited, while VTA stimulation promoted, cocaine-seeking behavior during early withdrawal. Blockade of phasic activated D1 receptors in the NAc core also strongly inhibited cue-induced cocaine-seeking--suggesting an important role of phasic DA activity in the VTA to NAc core circuit. Next, we examined the role of VTA acetylcholine receptors (AChRs) and N-methyl-D-aspartate receptors (NMDARs) in regulating both NAc core phasic DA release and cue-induced cocaine-seeking. In cocaine naïve subjects, VTA infusion of the nicotinic acetylcholine receptor (AChR) antagonist mecamylamine, the muscarinic AChR antagonist scopolamine, or the NMDAR antagonist AP-5, led to robust attenuation of phasic DA release in the NAc core. During early cocaine withdrawal, VTA infusion of AP-5 had limited effects on NAc phasic DA release and cue-induced cocaine-seeking while VTA infusion of mecamylamine or scopolamine robustly inhibited both phasic DA release and cocaine-seeking. The results demonstrate that VTA AChRs, but not NMDARs, strongly regulate cue-induced cocaine-seeking and phasic DA release during early cocaine withdrawal.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetylcholine; Drug-seeking; NMDA; Nucleus accumbens; Phasic dopamine; Ventral tegmental area

Mesh:

Substances:

Year:  2013        PMID: 23850572      PMCID: PMC3865076          DOI: 10.1016/j.neuropharm.2013.07.001

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  61 in total

Review 1.  Neuroplastic alterations in the limbic system following cocaine or alcohol exposure.

Authors:  Garret D Stuber; F Woodward Hopf; Kay M Tye; Billy T Chen; Antonello Bonci
Journal:  Curr Top Behav Neurosci       Date:  2010

2.  Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence.

Authors:  Marc N Potenza; Kwang-ik Adam Hong; Cheryl M Lacadie; Robert K Fulbright; Keri L Tuit; Rajita Sinha
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

3.  Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice.

Authors:  T Rasmussen; P Sauerberg; E B Nielsen; M D Swedberg; C Thomsen; M J Sheardown; L Jeppesen; D O Calligaro; N W DeLapp; C Whitesitt; J S Ward; H E Shannon; F P Bymaster; A Fink-Jensen
Journal:  Eur J Pharmacol       Date:  2000-08-25       Impact factor: 4.432

4.  Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration.

Authors:  M Behnam Ghasemzadeh; Preethi Vasudevan; Chad Giles; Anthony Purgianto; Chad Seubert; John R Mantsch
Journal:  Brain Res       Date:  2011-06-23       Impact factor: 3.252

5.  Optogenetic interrogation of dopaminergic modulation of the multiple phases of reward-seeking behavior.

Authors:  Antoine R Adamantidis; Hsing-Chen Tsai; Benjamin Boutrel; Feng Zhang; Garret D Stuber; Evgeny A Budygin; Clara Touriño; Antonello Bonci; Karl Deisseroth; Luis de Lecea
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

Review 6.  Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling.

Authors:  Christian Lüscher; Robert C Malenka
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

7.  Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Frank Telang; Joanna S Fowler; Kith Pradhan; Millard Jayne; Jean Logan; Rita Z Goldstein; Nelly Alia-Klein; Christopher Wong
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

8.  Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats.

Authors:  R Ito; J W Dalley; S R Howes; T W Robbins; B J Everitt
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

9.  Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety.

Authors:  Larry S Zweifel; Jonathan P Fadok; Emmanuela Argilli; Michael G Garelick; Graham L Jones; Tavis M K Dickerson; James M Allen; Sheri J Y Mizumori; Antonello Bonci; Richard D Palmiter
Journal:  Nat Neurosci       Date:  2011-04-17       Impact factor: 24.884

10.  Input-specific control of reward and aversion in the ventral tegmental area.

Authors:  Stephan Lammel; Byung Kook Lim; Chen Ran; Kee Wui Huang; Michael J Betley; Kay M Tye; Karl Deisseroth; Robert C Malenka
Journal:  Nature       Date:  2012-10-14       Impact factor: 49.962

View more
  16 in total

Review 1.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

2.  Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine.

Authors:  L E Mueller; M A Kausch; T Markovic; D A A MacLaren; D M Dietz; J Park; S D Clark
Journal:  Behav Brain Res       Date:  2014-10-01       Impact factor: 3.332

3.  Functional characterization of a novel opioid, PZM21, and its effects on the behavioural responses to morphine.

Authors:  Lucja Kudla; Ryszard Bugno; Urszula Skupio; Lucja Wiktorowska; Wojciech Solecki; Adam Wojtas; Krystyna Golembiowska; Ferenc Zádor; Sándor Benyhe; Szymon Buda; Wioletta Makuch; Barbara Przewlocka; Andrzej J Bojarski; Ryszard Przewlocki
Journal:  Br J Pharmacol       Date:  2019-12-08       Impact factor: 8.739

4.  Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling.

Authors:  Robert J Wickham; Eric J Nunes; Shannon Hughley; Phillip Silva; Sofia N Walton; Jinwoo Park; Nii A Addy
Journal:  Neuropharmacology       Date:  2017-09-21       Impact factor: 5.250

5.  Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.

Authors:  N A Addy; E J Nunes; R J Wickham
Journal:  Behav Brain Res       Date:  2015-04-09       Impact factor: 3.332

6.  Muscarinic, but not nicotinic, acetylcholine receptor blockade in the ventral tegmental area attenuates cue-induced sucrose-seeking.

Authors:  Nii A Addy; Eric J Nunes; Robert J Wickham
Journal:  Behav Brain Res       Date:  2015-05-28       Impact factor: 3.332

7.  Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues.

Authors:  R J Wickham; W B Solecki; E J Nunes; N A Addy
Journal:  Neuroscience       Date:  2015-06-17       Impact factor: 3.590

8.  Muscarinic acetylcholine receptor binding affinities of pethidine analogs.

Authors:  Na-Ra Lee; Xuan Zhang; Mahesh Darna; Linda P Dwoskin; Guangrong Zheng
Journal:  Bioorg Med Chem Lett       Date:  2015-10-19       Impact factor: 2.823

9.  Examining the role of muscarinic M5 receptors in VTA cholinergic modulation of depressive-like and anxiety-related behaviors in rats.

Authors:  Eric J Nunes; Laura E Rupprecht; Daniel J Foster; Craig W Lindsley; P Jeffrey Conn; Nii A Addy
Journal:  Neuropharmacology       Date:  2020-04-05       Impact factor: 5.250

10.  The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway.

Authors:  Nii A Addy; Eric J Nunes; Shannon M Hughley; Keri M Small; Sarah J Baracz; Joshua L Haight; Anjali M Rajadhyaksha
Journal:  Neuropsychopharmacology       Date:  2018-05-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.